Literature DB >> 26269508

A single injection of collagenase clostridium histolyticum for the treatment of moderate Dupuytren's contracture: a 2 year follow-up of 47 patients.

J McFarlane1, A M Syed2, T F Sibly2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26269508     DOI: 10.1177/1753193415597421

Source DB:  PubMed          Journal:  J Hand Surg Eur Vol        ISSN: 0266-7681


× No keyword cloud information.
  4 in total

1.  Collagenase injections for Dupuytren's disease: prospective cohort study assessing 2-year treatment effect durability.

Authors:  Anna Lauritzson; Isam Atroshi
Journal:  BMJ Open       Date:  2017-03-15       Impact factor: 2.692

2.  Collagenase Clostridium Histolyticum Injection for Dupuytren Contracture: 2-Year Follow-up.

Authors:  Suresh K Nayar; Dennis Pfisterer; John V Ingari
Journal:  Clin Orthop Surg       Date:  2019-08-12

3.  Long-Term Outcomes of Collagenase Clostridium Histolyticum Injection for Palmar Dupuytren's Deformity Correction.

Authors:  Sarang Kasture; Raj Sakamuri
Journal:  Cureus       Date:  2021-11-27

4.  Collagenase injections for Dupuytren disease: 3-year treatment outcomes and predictors of recurrence in 89 hands.

Authors:  Jesper Nordenskjöld; Anna Lauritzson; Anna Åkesson; Isam Atroshi
Journal:  Acta Orthop       Date:  2019-09-10       Impact factor: 3.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.